Literature DB >> 10758259

Quantifying behavioral disturbance in Alzheimer's disease patients.

M F Weiner1, R Tractenberg, L Teri, R Logsdon, R G Thomas, A Gamst, L J Thal.   

Abstract

In the course of a four-month study of interventions for behavioral disturbances in Alzheimer's disease (AD) patients, the following assessment instruments were examined for validity: the clinical global impression of change (CGIC), Cohen-Mansfield agitation inventory (CMAI); CERAD behavioral rating scale for dementia (BRSD), revised memory and behavioral problems checklist (RMBPC) and the agitated behavior in dementia scale (ABID). The four specific behavioral/agitation scales had excellent cross-sectional and longitudinal correlations with each other, suggesting high validity, but changes as indicated by CGIC scores did not correlate well with change scores on the other instruments. We conclude that specific behavioral instruments are preferable to the more general CGIC for detecting and quantifying behavioral disturbances in AD patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758259     DOI: 10.1016/s0022-3956(99)00042-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

1.  Psychometric analysis of the Revised Memory and Behavior Problems Checklist: factor structure of occurrence and reaction ratings.

Authors:  David L Roth; Louis D Burgio; Laura N Gitlin; Dolores Gallagher-Thompson; David W Coon; Steven H Belle; Alan B Stevens; Robert Burns
Journal:  Psychol Aging       Date:  2003-12

2.  Instruments to measure behavioural and psychological symptoms of dementia.

Authors:  Rianne M van der Linde; Blossom C M Stephan; Tom Dening; Carol Brayne
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-05       Impact factor: 4.035

3.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.